Kursprognose für Artiva Biotherapeutics Inc (ARTV)

$4.220

+0.020 (+0.48%)Zum Schluss

Kursprognosen

1-Day Price Prediction

-0.20%

1-Week Prediction

+1.92%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

ARTV-Prognose durch Analyse ähnlicher Charts

Alphio's ARTV stock price prediction model matches the current Artiva Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.21 (-0.20%). The 1-week path is $4.30 (+1.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich Artiva Biotherapeutics Inc-Aktien kaufen?

Artiva Biotherapeutics is not a good buy right now due to significant financial losses and recent downgrades by analysts. The current price is $4.19, which is near the downgraded price target of $4 from Jefferies and Wedbush. The RSI is extremely low at 12.93, indicating oversold conditions, but the company's ongoing net losses, which reached $23.5 million in Q1 2026, and the discontinuation of its lead program due to safety concerns, present substantial risks. The main risk is the potential for further declines in share price given the negative sentiment and recent analyst downgrades.

ARTV schloss am Wednesday bei $4.22, nachdem der Kurs +0.48% gestiegen ist

Artiva Biotherapeutics Inc (ARTV) last closed at $4.2199998, gaining +0.48%. These facts feed the 1-day and 1-week ARTV price prediction above.

Prognose-Treiber

Die Prognose-Treiber von Artiva Biotherapeutics Inc (ARTV) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Saisonalitätsanalyse für ARTV

Historically the probability of a positive November return for ARTV is 18.60%. June offers the highest probability of a positive month at 51.22%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…